Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress

被引:179
作者
George, Jacob [1 ]
Struthers, Allan D. [1 ]
机构
[1] Ninewells Hosp & Med Sch, Div Med & Therapeut, Dundee DD1 9SY, Scotland
关键词
allopurinol; vascular oxidative stress; vascular endothelial dysfunction;
D O I
10.2147/VHRM.S4265
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
Oxidative stress plays an important role in the progression of vascular endothelial dysfunction. The two major systems generating vascular oxidative stress are the NADPH oxidase and the xanthine oxidase pathways. Allopurinol, a xanthine oxidase inhibitor, has been in clinical use for over 40 years in the treatment of chronic gout. Allopurinol has also been shown to improve endothelial dysfunction, reduce oxidative stress burden and improve myocardial efficiency by reducing oxygen consumption in smaller mechanistic studies involving various cohorts at risk of cardiovascular events. This article aims to explain the role of xanthine oxidase in vascular oxidative stress and to explore the mechanisms by which allopurinol is thought to improve vascular and myocardial indices.
引用
收藏
页码:265 / 272
页数:8
相关论文
共 82 条
[1]
Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure [J].
Amado, LC ;
Saliaris, AP ;
Raju, SVY ;
Lehrke, S ;
John, MS ;
Xie, JS ;
Stewart, G ;
Fitton, T ;
Minhas, KM ;
Brawn, J ;
Hare, JM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 39 (03) :531-536
[2]
AUGUSTIN AJ, 1994, INVEST OPHTH VIS SCI, V35, P3897
[3]
Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease [J].
Baldus, S ;
Köster, R ;
Chumley, P ;
Heitzer, T ;
Rudolph, V ;
Ostad, MA ;
Warnholtz, A ;
Staude, HJ ;
Thuneke, F ;
Koss, K ;
Berger, J ;
Meinertz, T ;
Freeman, BA ;
Münzel, T .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 (09) :1184-1190
[4]
Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications [J].
Berry, CE ;
Hare, JM .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03) :589-606
[5]
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension [J].
Butler, R ;
Morris, AD ;
Belch, JJF ;
Hill, A ;
Struthers, AD .
HYPERTENSION, 2000, 35 (03) :746-751
[6]
Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress [J].
Cai, H ;
Harrison, DG .
CIRCULATION RESEARCH, 2000, 87 (10) :840-844
[7]
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy [J].
Cappola, TP ;
Kass, DA ;
Nelson, GS ;
Berger, RD ;
Rosas, GO ;
Kobeissi, ZA ;
Marbán, E ;
Hare, JM .
CIRCULATION, 2001, 104 (20) :2407-2411
[8]
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients [J].
Cardillo, C ;
Kilcoyne, CM ;
Cannon, RO ;
Quyyumi, AA ;
Panza, JA .
HYPERTENSION, 1997, 30 (01) :57-63
[9]
IMPROVEMENT OF CARDIAC-FUNCTION BY ALLOPURINOL IN PATIENTS UNDERGOING CARDIAC-SURGERY [J].
CASTELLI, P ;
CONDEMI, AM ;
BRAMBILLASCA, C ;
FUNDARO, P ;
BOTTA, M ;
LEMMA, M ;
VANELLI, P ;
SANTOLI, C ;
GATTI, S ;
RIVA, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (01) :119-125
[10]
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy [J].
Cicoira, M ;
Zanolla, L ;
Rossi, A ;
Golia, G ;
Franceschini, L ;
Brighetti, G ;
Zeni, P ;
Zardini, P .
AMERICAN HEART JOURNAL, 2002, 143 (06) :1107-1111